1) Kampylafka EI, Alexopoulos H, Dalakas MC, Tzioufas AG:Immunotherapies for neurological manifestations in the context of systemic autoimmunity. Neurotherapeutics 2016;13(1):163-78 2) Lee HJ, Chang SH, Kang EH, et al:A Case of primary Sjögren's syndrome presenting as mass-like encephalitis, with progression to neuromyelitis optica spectrum disorder. Arch Rheumatol 2017;32(4):353-7 3) Schattner A, Friedman J, Klepfish A:Thrombotic thrombocytopenic purpura as an initial presentation of primary Sjögren's syndrome. Clin Rheumatol 2002;21(1):57-9 4) Furukawa T, Matsui N, Tanaka K, et al:A case of neuromyelitis optica spectrum disorder (NMOSD) with Sjögren's syndrome manifested only brain involvement by preceding parotitis. Rinsho Shinkeigaku 2017;57(2):77-81 5) Xu X, Zhu T, Wu D, Zhang L:Sjögren's syndrome initially presented as thrombotic thrombocytopenic purpura in a male patient:a case report and literature review. Clin Rheumatol 2018;37(5):1421-6 6) Lalji A, Izbudak I, Birnbaum J:Cortical blindness and not optic neuritis as a cause of vision loss in a Sjogren's syndrome (SS) patient with the neuromyelitis optica spectrum disorder (NMOSD):Challenges of ascribing demyelinating syndromes to SS:a case report. Medicine (Baltimore) 2017;96(34):e7454 7) Konttinen YT, Kinnunen E, von Bonsdorff M, et al:Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjögren's syndrome. Arthritis Rheum 1987;30(3):339-44 8) Yoon KH, Fong KY, Koh DR, Suri R:Central pontine myelinolysis--a rare manifestation of CNS Sjogren's syndrome. Lupus 2000;9(6):471-3 9) Rogers SJ, Williams CS, Román GC:Myelopathy in Sjögren's syndrome:role of nonsteroidal immunosuppressants. Drugs 2004;64(2):123-32 10) Bak E, Yang HK, Hwang JM:Optic neuropathy associated with primary Sjögren's syndrome:A case series. Optom Vis Sci 2017;94(4):519-26 11) Gerraty RP, McKelvie PA, Byrne E:Aseptic meningoencephalitis in primary Sjögren's syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy. Acta Neurol Scand 1993;88(4):309-11 12) Ging K, Mono ML, Sturzenegger M, et al:Peripheral and central nervous system involvement in a patient with primary Sjogren's syndrome:a case report. J Med Case Rep 2019;13(1):165 13) Takakura Y, Murai H, Furuya H, et al:A case of brachial amyotrophic diplegia accompanied with Sjögren's syndrome presenting good response to immunotherapies in the early course of the disease. Rinsho Shinkeigaku 2005;45(5):346-50 14) Chen WH, Yeh JH, Chiu HC:Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sjögren's syndrome. Eur Neurol 2001;45(4):270-4 15) Kujawska-Danecka H, Masiak A, Smoleńska Z, Zdrojewski Z:Involvement of the peripheral nervous system in systemic connective tissue diseases:report on clinical cases. Ann Acad Med Stetin 2011;57(3):33-8 16) Sawamura M, Oishi W, Nakanishi E, et al:Case of ataxic sensory neuronopathy associated with Sjögren's syndrome. Rinsho Shinkeigaku 2014;54(5):413-6 17) Hebbar M, Hebbar-Savean K, Hachulla E, et al:Participation of cryoglobulinaemia in the severe peripheral neuropathies of primary Sjögren's syndrome. Ann Med Interne (Paris) 1995;146(4):235-8 18) Mori K, Iijima M, Koike H, et al:The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005;128(Pt 11):2518-34 19) Chiu HC, Chen WH, Yeh JH:Double filtration plasmapheresis in the treatment of inflammatory polyneuropathy. Ther Apher 1997;1(2):183-6